0

Zardaverine

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP101975104
CAS101975-10-4
Structure
MDL NumberMFCD00867059
Molecular Weight268.22
InChI KeyHJMQDJPMQIHLPB-UHFFFAOYSA-N; 2.5 μM IC50 (for PDE III)
Descriptionphosphodiesterase inhibitor
Size5MG
1

A Dual Phosphodiesterase Inhibitor, Zardaverine (Type 3/4), Enhances Motility of Frozen-thawed Boar Sperm

J Jeong, S J Sa, H Chung, S Baek, I Choi

Cryo Letters. May/Jun 2018;39(3):196-200.

PMID: 30059566

1

Cytotoxicity of Zardaverine in Embryonal Rhabdomyosarcoma From a Costello Syndrome Patient

Donna M Cartledge, Katherine M Robbins, Katherine M Drake, Rachel Sternberg, Deborah L Stabley, Karen W Gripp, E Anders Kolb, Katia Sol-Church, Andrew D Napper

Front Oncol. 2017 Apr 3;7:42.

PMID: 28421158

1

Phosphodiesterase 3/4 Inhibitor Zardaverine Exhibits Potent and Selective Antitumor Activity Against Hepatocellular Carcinoma Both in Vitro and in Vivo Independently of Phosphodiesterase Inhibition

Liping Sun, Haitian Quan, Chengying Xie, Lei Wang, Youhong Hu, Liguang Lou

PLoS One. 2014 Mar 5;9(3):e90627.

PMID: 24598942

1

The Effect of Zardaverine, an Inhibitor of Phosphodiesterase Isoenzymes III and IV, on Endotoxin-Induced Airway Changes in Rats

J C Kips, G F Joos, R A Peleman, R A Pauwels

Clin Exp Allergy. 1993 Jun;23(6):518-23.

PMID: 8369979

1

Zardaverine and Aerosolised Iloprost in a Model of Acute Respiratory Failure

R T Schermuly, H Leuchte, H A Ghofrani, N Weissmann, F Rose, M Kohstall, H Olschewski, C Schudt, F Grimminger, W Seeger, D Walmrath

Eur Respir J. 2003 Aug;22(2):342-7.

PMID: 12952271

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode